Print

BrainStorm Cell Therapeutics Inc. Will Host a Conference Call to Update Shareholders on Upcoming Trial and Other Exciting Developments  
11/29/2012 9:35:12 AM

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTC:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that its senior management will hold a conference call on Tuesday, December 11, 2012 at 8:00 a.m. EST in Hebrew and at 8:45 a.m. EST in English. Dr. Adrian Harel, Chief Executive Officer, Mr. Chaim Lebovits, President, Ms. Liat Sossover, Chief Financial Officer, and Prof. Eldad Melamed, PhD, Chief Medical Advisor, will update on the upcoming trial and other exciting developments.
//-->